Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition).

TH Open · 2019 · PMC6660472 · PMID 31360828

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Comparing the mean ESS of the 12 patients before and after 1 month of treatment: 3.99 versus 2.79, the decrease was 1.20 in the ESS score, being highly significant with a p < 0.001 (***).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.